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Abstract: The development of site-selective chemistry targeting
the canonical amino acids enables the controlled installation of
desired functionalities into native peptides and proteins. Such
techniques facilitate the development of polypeptide conjugates
to advance therapeutics, diagnostics, and fundamental science.
We report a versatile and selective method to functionalize
peptides and proteins through free-radical-mediated dechalco-
genation. By exploiting phosphine-induced homolysis of the
CSe and CS bonds of selenocysteine and cysteine, respec-
tively, we demonstrate the site-selective installation of groups
appended to a persistent radical trap. The reaction is rapid,
operationally simple, and chemoselective. The resulting ami-
nooxy linker is stable under a variety of conditions and
selectively cleavable in the presence of a low-oxidation-state
transition metal. We have explored the full scope of this
reaction using complex peptide systems and a recombinantly
expressed protein.
Introduction
The diverse array of chemical functionality displayed by
the 20 canonical amino acids presents both a challenge and an
opportunity for the site-selective functionalization of peptides
and proteins. A broad range of reactions have been reported
to modify the majority of the proteinogenic residues,[1–4]
providing tools to enable the study and manipulation of
biological systems, and the preparation of therapeutic and
diagnostic agents. To be widely applicable to peptide/protein
bioconjugation such reactions must be chemoselective, high
yielding, rapid, and operationally simple. The number of
modified isoforms produced by a technique will be dictated by
both the chemoselectivity of the chemistry and the relative
abundance of the target amino acid. Reactions that select the
more abundant amino acids, such as lysine (Lys), which
accounts for approximately 6% of residues across the human
proteome, are liable to produce a mixture of isoforms which
can be challenging to purify.[2, 5] Conversely, the amino acid
cysteine (Cys) constitutes just 2% of our proteome. Due to
this limited presence, coupled with the enhanced nucleophi-
licity of the thiol sidechain and ease of incorporation of non-
native Cys via site-directed mutagenesis, reactions that target
this residue have been widely adopted throughout industry
and academia.[6, 7]
The “standard” Cys-specific conjugation methods employ
electrophilic moieties such as a-halocarbonyl[7,8] and malei-
mide[7, 9] groups (Figure 1). However, such components pres-
ent chemoselectivity and stability challenges, respectively.
More recently, bromomaleimides,[10] perfluoroaromatics,[11]
phosphonamidates,[12] allenamides,[13] vinyl/alkynyl,[14] and
acrylate groups[15] have been investigated to selectively label
Cys residues. Methods beyond simple addition chemistry,
such as thiol-ene/yne click reactions,[16] metal-catalyzed[17] and
metal-free arylation,[18] and oxidative elimination to dehy-
droalanine (Dha) with subsequent Michael[19] or radical
addition,[20–22] have also been explored. Despite the broad
range of chemistry developed to target this residue, challeng-
es persist regarding reaction efficiency, chemoselectivity,
tolerance, operational simplicity, and conjugate stability.
Thus, novel methods are in high demand.
Figure 1. Current approaches to selective peptide and protein modifi-
cation at selenocysteine (Sec) and cysteine (Cys) residues.
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Selenocysteine (Sec) represents an alternative conjuga-
tion handle to Cys. Known as the 21st proteinogenic amino
acid, biological expression of Sec is rare; only 25 selenopro-
teins have been identified within the human proteome.[23]
Incorporation of this amino acid is facilitated by a dedicated
suite of proteins and a Sec Insertion Sequence Element
(SECIS), a stem-loop RNA structure that repurposes the opal
codon (UGA) for Sec installation. Thus, selenoproteins can
be prepared using modified expression techniques, albeit in
lower yield than can be achieved with standard recombinant
expression.[24–27] The selenol moiety of the Sec residue exhibits
enhanced nucleophilicity over the thiol group of Cys due to
the increased polarizability of the selenium atom.[28] With
a low redox potential (381 mV), Sec is readily oxidized, thus
its predominant role in nature is as a scavenger for damaging
oxidizing agents. Strategies to site-selectively functionalize
Sec-containing peptides and proteins include metal-catalyzed
and metal-free arylation,[29] heteroarylation, alkylation and
allenamidation.[30]
Beyond applications in bioconjugation, both Cys and Sec
residues have been utilized to facilitate the chemical ligation
of peptide sequences. The technique of native chemical
ligation (NCL)[31, 32] enables peptides bearing an N-terminal
Cys residue to be chemoselectively linked to sequences
containing a C-terminal thioester via a native amide bond.
Further developments to this powerful method[33] include the
use of Sec-containing peptides[34–36] and selenoester peptides
to accelerate the ligation reaction.[37] The development of
diselenide-selenoester ligation (DSL) employs both seleni-
um-containing fragments to enable rapid, additive-free pep-
tide ligation.[38–43] Protocols that facilitate the post-ligation
conversion of internal Cys and Sec residues to alanine (Ala),
via desulfurization and deselenization, respectively,[44, 45] per-
mit peptide ligation at sites that contain this more abundant
residue. Further developments in this field include the
utilization of non-proteinogenic thiolated and selenolated
residues, which, when coupled with dechalcogenation,[46, 47]
grant access to a broad range of ligation junctions, dramat-
ically enhancing the scope of the technique.
It is proposed that the desulfurization and deselenization
pathways (mediated by a phosphine) proceed, in both cases,
via a free-radical process (Figure 2). Desulfurization of Cys-
containing peptides requires the initial formation of a thiyl
radical (usually via addition of the initiator, VA-044) which
adds into the phosphine (TCEP—tris(2-carboxyethyl)phos-
phine) to form a phosphoranyl radical. Sec undergoes this
reaction spontaneously under ambient conditions. Subse-
quent homolysis of the CS/CSe bond of the phosphoranyl
sulphide/selenide produces an alanyl radical (with release of
the phosphine sulfide/selenide). This intermediate radical
species will then abstract an H-atom from a thiol additive to
yield an Ala residue at this position. In the case of
deselenization, the alanyl radical can be trapped by a peroxide
salt (Oxone)[48, 49] or O2
[50] to install a hydroxyl group at the
ligation junction, and thus afford the amino acid serine (Ser;
Figure 2). Successful trapping of the alanyl radical suggests
potential scope for the development of a novel bioconju-
gation strategy. Previous research has described the use of
thiophosphonium salts to induce the conversion of disulfides
to thioethers[51] and also as a method to deuterate Cys-
containing peptides via desulfurization.[52] However, to our
knowledge, free-radical-mediated dechalcogenation has not
been explored as a method to install groups of interest into
peptides and proteins. Interception of this pathway, using
a suitable functionalized trapping agent, would potentially be
a powerful addition to the synthetic methodology within this
field (Figure 3).
The persistent radical, TEMPO (2,2,6,6-tetramethyl-1-
piperidine-1-oxyl), would be an ideal trapping reagent in this
context due to the stability of the sterically shielded nitroxyl
radical. This reaction is likely to be chemoselective in the
presence of native proteinogenic chemical functionality and
rapid, assuming it can outcompete H-atom abstraction.
Crucially, the generation and trapping of a radical at the b-
carbon of Sec or Cys, via the described pathway, would
maintain the integrity of the a-stereocenter of the target
residue. By applying this approach, utilizing TEMPO deriv-
atives that carry a broad range of desirable moieties, we
demonstrate the first example of site-selective functionaliza-
tion via trapping of free-radical-mediated dechalcogenation,
representing an entirely novel method of peptide and protein
modification (Figure 3).
Figure 2. Proposed mechanism of free-radical-mediated deselenization
with addition of oxone or O2 to afford serine (Ser) at the site of
deselenization.
Figure 3. Trapping of the alanyl radical produced from free-radical-
mediated deselenization/desulfurization at Sec/Cys residues using
a TEMPO-based persistent radical.
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Results and Discussion
For our initial investigations into this concept, we
synthesized the small Sec-containing model peptide 1a (H-
UAF-OMe) and subjected it to standard deselenization
conditions on an analytical scale: 125 mM TCEP (50 molar
eq.), 62.5 mM TEMPO (25 equiv.) at 2.5 mM wrt the selenol
monomer (1.25 mM wrt to the diselenide dimer), in neutral
buffer containing a high concentration of a chaotropic salt
(6 M Gdn·HCl, 0.1 M Na2HPO4, pH 6.5).
A co-solvent (20 % methanol) was included to facilitate
dissolution of the reagents and the reaction run at 37 8C. Full
conversion to 2 b was complete within 6 hours (Table 1,
entry 1; reaction monitored by analytical HPLC). Gratify-
ingly, the undesired Ala by-product, produced via quenching
of the alanyl radical by H-atom abstraction from a suitable
donor, was not observed. The persistent TEMPO radical is
able to outcompete this process to yield quantitative con-
version to the desired conjugate. To enhance the rate of
conjugation several variables were then explored, including;
temperature, pH, stoichiometry of reagents, co-solvent, and
the use of various additives (see Table 1, Figure 4 and SI for
details). The reaction was observed to proceed at a slightly
slower rate if the excess of TCEP was dropped to 25 equiv.
and failed to reach completion over 16 hrs with 5 equiv.
(Figure 4B). Doping the solution with TCEP and TEMPO
twice over the first hour pushed the reaction to completion
within 3 hours (entry 2). Doping also enabled us to lower the
excess of TEMPO to 5 equiv. without dramatically decreasing
the rate of reaction (entry 3). Running the reaction without
a co-solvent did not affect the rate (entry 5). Raising the
temperature to 50 8C further accelerated the reaction elimi-
nating the need for doping, allowing us to employ a more
acceptable overall stoichiometry of TEMPO (entry 6). Dop-
ing under these conditions dropped the conversion rate to
2 hours (entry 7) and allowed us to again reduce the excess of
TCEP and TEMPO, to 10 and 2 equiv. respectively (entry 8).
To further accelerate the rate of the reaction, we next
explored the introduction of several additives to facilitate
production of the alanyl radical. Cu(OAc)2, Mn(OAc)3, the
radical initiator VA-044, and the photosensitive dye, Eosin Y,
were all evaluated (Figure 4D). Each additive successfully
enhanced the rate to afford complete conversion within 2 hrs.
Mn(OAc)3 gave the fastest conversion; 4 equiv. of Mn(OAc)3
enabled us to decrease the excess of TEMPO to 2 equiv. with
complete conversion observed in under 60 minutes, without
doping (entry 10). However, doping with 2 equiv. of Mn-
(OAc)3 did allow us to push the reaction to completion within
30 minutes (entry 11). Additionally, the presence of an
additive accelerated the reaction at lower concentrations of
peptide 1a ; a catalytic amount of the dye Eosin Y (5 mol %),
with doping under blue LEDs, afforded full conversion at
0.2 mM over 2 hours (entry 12). The need for a balance
between the rate of the reaction and a reasonable stoichiom-
etry of TEMPO, which will carry the desired group for
conjugation, led us to conclude that entry 10 represented the
optimal set of conditions to take forward (referred to
hereafter as protocol A, see Table S1). These conditions were
repeated on a larger scale (8 mg of model peptide 1a) and the
product purified via HPLC to afford the desired conjugate 2a
in excellent yield (83 %, Table 2, entry 13).
Based on the proposed mechanism of dechalcogenation
under the described conditions, it is assumed that epimeriza-
tion of the a-carbon at the target residue should not occur. To
confirm this, model peptide 1b was
prepared carrying the d-isomer of
Sec (H-d-UAF-OMe) and subject-
ed to protocol A to yield conjugate
2b. Comparison of the 1H NMR
spectra for epimers 2a and 2b
clearly highlights that the signal
shifts observed for 2b are not pres-
ent in the NMR for 2a and vice
versa (Figure S36). Therefore, it can
be concluded that the integrity of
the stereochemistry at the target
residue remains intact throughout
the conjugation process. Confident
that we had fully optimized the
method, a range of TEMPO traps,
carrying potentially desirable func-
tionality, were then prepared from
either 4-amino-, carboxy-, oxo-, or
hydroxy-TEMPO (3–7, Figure 5),
using mild, well-established chemis-
try in high yield (see SI for details).
Tetraethylene glycol (tetra-EG)
polymer (3) was included to enable
the attachment of a group to mod-
ulate the stability of a polypeptide;
propargyl (4) and biotin (6) groups













1 2.5 37 20 50 25 0 – 6 h
2 2.5 37 20 50 25 2 – 3 h
3 2.5 37 20 50 5 2 – 4 h
4 2.5 37 20 25 5 2 – 4 h
5 2.5 37 0[d] 25 5 2 – 4 h
6 2.5 50 20 50 5 0 – 4 h
7 2.5 50 20 50 5 2 – 2 h
8 2.5 50 20 10 2 2 – 2 h
9 2.5 50 20 10 2 0 2 (Mn(OAc)3) 90 mins
10[e] 2.5 50 20 50 2 0 4 (Mn(OAc)3) 60 mins
11 2.5 50 20 50 5 2 2 (Mn(OAc)3) 30 mins
12 0.2 30 20 50 5 2 0.05 (Eosin Y)[f ] 2 h
[a] 20% methanol in ligation buffer (6 M Gdn·HCl, 0.1 M Na2HPO4, pH 7.0); degassing of the solution
was not required. [b] Addition of TCEP and TEMPO at stated equiv at 15 and 45 mins; entry 11 doped at
5 and 15 mins. [c] Reaction reached 100% conversion to 2a by the stated time, as determined by
analytical HPLC. [d] 100% ligation buffer (6 M Gdn·HCl, 0.1 M Na2HPO4, pH 7.0). [e] Conditions
selected as the optimal balance between rate and stoichiometry. [f ] Sample irradiated under blue LEDs,
temp. measured as approximately 30 8C.
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were explored to enable the isolation of tagged peptides/
proteins; a fluorophore (fluorescein, 5) was included for
imaging, and a cytotoxic drug (gemcitabine, 7) used to
demonstrate protein-drug conjugation (via a stable, non-
cleavable linker, thus relying on lysosomal degradation of the
conjugate for drug release). Each trap was then conjugated to
model peptide 1a using protocol A to demonstrate the
tolerance of the technique. The reactions all proceeded to
completion within 1 hour to afford the desired product in
good–excellent isolated yields (67–83%, products 8–12,
Table 2).
Although Sec provides a useful bioconjugation handle,
especially when employing peptide ligation to access large
peptides or small proteins, Cys is the target residue of choice
for researchers wishing to modify recombinantly expressed
proteins. Therefore, to test the potential of our reaction to
label Cys-containing peptides, the model H-CAF-OMe (13)
was prepared and conjugation reactions with TEMPO trialed
to afford conjugate 14 (Table S13). Although it was gratifying
to confirm that the procedure could be applied to trap the
alanyl radical produced via desulfurization of Cys, it was
observed that the standard protocol A did not give an optimal
rate for this model. It was also noted that use of Eosin Y as
a catalytic initiator resulted in production of an unidentified
impurity which co-eluted with the product. Therefore, the
stoichiometry of TCEP, TEMPO and Mn(OAc)3 was again
Figure 4. Data plots illustrating the effect of several variables on reaction rate (1a–2a); plots generated from integration of the desired product
peak (2a) relative to the starting peptide (1a) by analytical HPLC; see SI Figures S7–S16 for further details regarding reaction conditions.
Table 2: Yields of isolated peptide conjugates 2a, 8–12 from model
peptide 1a.
Entry Product Trap Yield [%]
13 2a TEMPO 83
14 8 tetra-EG (3) 72
15 9 propargyl (4) 80
16 10 fluorescein (5) 69
17 11 biotin (6) 78
18 12 gemcitabine (7) 67
Figure 5. TEMPO-based persistent radical traps 3–7.
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explored to determine the ideal conditions. It was observed
that 1 mM peptide, 50 equiv. TCEP, 2 equiv. TEMPO, 5 equiv.
Mn(OAc)3, 50 8C in 20% co-solvent in ligation buffer resulted
in full conversion to 14 over 2 hours (referred to hereafter as
protocol B). The model peptide Ac-CWHISKEY-NH2 (15)
was prepared to test the efficiency and chemoselectivity of the
conjugation at Cys against more diverse proteinogenic
chemical functionality. The isolated yields obtained on model
15 using protocol B with traps 3–7 were comparable to those
of the Sec model (16–20, 71–82 % yield, Table 3). No by-
products were observed from side-reactions with the nucle-
ophilic (Lys) or aromatic (His) residues within this peptide.
Quenching of the alanyl radical via H-atom abstraction from
the thiol groups of the Cys-containing peptides in solution was
a concern for this model. However, the Ala by-product was
not observed under the optimized conditions. Furthermore, to
ensure that the reaction did not result in the oxidation of
methionine (Met) residues, model peptide H-UWIMKY-NH2
(21) was synthesized and subjected to protocol A conditions
to afford conjugate 22 in good yield (68%, Figure S64) with
no detectable oxidation of the Met residue.
The chemoselectivity demonstrated using these model
peptides was encouraging, however, to ensure selectivity in
larger, more complex peptides, and to demonstrate a success-
ful one-pot ligation-functionalization protocol, the selenoest-
er peptide Ac-YEPLA-SePh (23) and selenopeptide H-
UHISKY-NH2 (24) were synthesized. Together, these models
contain the majority of the chemical functionality present in
larger protein systems, including; a nucleophilic amine (Lys),
carboxylic acid (glutamic acid, Glu), aromatic groups (tyro-
sine, Tyr, and His), a primary alcohol (Ser), a primary amide
(C-terminus) and an aliphatic, sterically bulky group (leucine,
Leu). Peptide ligation of 24 via DSL[38] proceeded in buffer
(6 M Gdn·HCl, 0.1 M Na2HPO4, pH 6.5) at 2.5 mM wrt to the
diselenide dimer (5 mM wrt the selenol monomer) with
a slight excess of the selenoester 23 (1.05 equiv.). Precipita-
tion of diphenyl diselenide (DPDS) within 60 seconds indi-
cated that the ligation had reached completion; this precip-
itate was extracted with hexane and a sample of the solution
was removed for analysis. The crude ligation solution was
partitioned into five equal volumes and the required equiv-
alents of the reagents added from stock solutions; TCEP
(0.625 M stock solution), TEMPO trap (3–7) (0.1 M stock
solution) and Mn(OAc)3 (0.1 M stock solution). The reactions
were diluted with buffer and DMSO (up to 20% co-solvent)
to give the final concentrations as described by conjugation
protocol A: 2.5 mM peptide wrt selenol monomer, 125 mM
TCEP (50 equiv.), 5 mM TEMPO (2 equiv.), 10 mM Mn-
(OAc)3 (4 equiv.). The conjugations were heated at 50 8C for
1 hour; once the starting material was shown to be consumed
by analytical HPLC, the crude reactions were purified by
preparative HPLC to yield the desired products 27–31 in high
yield (69–80 %) in one-pot over two steps (Figure 6).
After demonstrating that Cys can be modified under the
conjugation conditions containing Mn(OAc)3 as an additive
(products 16–20, Table 3), we were intrigued to explore the
selective modification of Sec in the presence of Cys. To
confirm that an internal Cys present in the sequence would
not interfere with the modification of Sec, the model peptide
H-UHISCY-NH2 (25) was synthesised and the one-pot
ligation-conjugation attempted with selenoester 23 under
conditions similar to protocol A, but with omission of Mn-
(OAc)3, run at 37 8C (50 equiv. TCEP, 5 equiv. TEMPO at
a final peptide concentration of 2.5 mM—labelled as proto-
col C). The reaction was monitored via HPLC and observed
to reach completion over 4 hours. The reaction mixture was
purified to yield the desired product 32 in an excellent yield
(90 %) over the two steps, with no apparent interference from
the internal Cys residue (Figure 6). This ligation-conjugation
protocol was successfully repeated with these peptide models
using the propargyl-TEMPO (4) and biotin-TEMPO (6) traps
to yield products 33 and 34 in 83% and 71% respectively. No
conjugation or desulfurization at the internal Cys residue was
detected under these conditions. Crucially, the presence of the
internal thiol (an excellent H-atom source) within the peptide
sequence did not quench the conjugation reaction at the Sec
residue.
To demonstrate the application of our method to a liga-
tion-conjugation protocol using N-terminal Cys residues with
a selenoester peptide, we synthesized the model peptide H-
CHISKY-NH2 (26) and submitted it to a ligation-conjugation
protocol with selenoester 23. However, post-ligation the
internal Cys residue (the intended site of conjugation) reacts
with any excess of the selenoester starting peptide to give an
undesired pendent selenoester. This by-product is not ob-
served using an N-terminal Sec residue for ligation as the low
redox potential of this residue leads to rapid oxidation to the
diselenide product. Treatment with hydroxylamine results in
successful hydrolysis of the selenoester by-product to yield
the desired thiol, however, use of this additive prevents direct
conjugation using the crude solution. We therefore switched
to a two-pot protocol for model peptide 26. Ligation of the
two peptides was followed by extraction of DPDS, addition of
hydroxylamine, and purification of the ligated product to
afford the desired peptide 35 in 77 % yield (Figure S85).
When applying protocol B (optimized for model 15 ; Ac-
CWHISKEY-NH2) to the purified ligation product using
propargyl-TEMPO 4, it was found that a slightly higher excess
of Mn(OAc)3 (10 equiv.) at 2.5 mM wrt the starting peptide
was required to successfully modify an internal Cys residue
Table 3: Isolated yields of peptide conjugates 16–20 from model peptide
15.
Entry Product Trap Yield [%]
19 16 tetra-EG (3) 80
20 17 propargyl (4) 82
21 18 fluorescein (5) 71
22 19 biotin (6) 73
23 20 gemcitabine (7) 80
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(labelled protocol D: Table S1). These conditions afforded
the desired conjugate 28 in 81% conversion (by HPLC) over
4 hours. The conjugation was repeated on an isolatable scale
using peptide 35 with propargyl-TEMPO 4 and gemcitabine-
TEMPO 7 to yield the desired conjugates (28 and 31) over the
same time course in 67% and 62% isolated yield, respectively
(52 % and 48% over two steps).
Our investigation of one-pot ligation-conjugation using
model peptide 25 (H-UHISCY-NH2) demonstrates that we
can selectively modify a Sec residue in the presence of Cys. To
further explore this selectivity, peptide 25 was subjected to the
mild conjugation protocol C (i.e. no Mn(OAc)3) using the
propargyl-TEMPO trap 4 and purified to give mono-modified
peptide 36 in 68% yield (Figure S90). This peptide was then
submitted to the standard protocol A with the tetra-EG trap 3
and the di-modified peptide 37 was successfully isolated in
64% yield (Figure S92), thus demonstrating that alternative
moieties can be selectively installed at Sec and Cys residues
by tuning the reaction conditions.
The stability of polypeptide conjugates is a vital aspect of
any bioconjugation method. It is crucial, for instance, that
protein-drug conjugates do not prematurely release their
cytotoxic cargo before reaching their target site. Conversely,
applications within proteomics and protein profiling require
selectively cleavable linkers to release isolated protein
material for analysis. To investigate the stability of our
aminooxy linker, TEMPO-peptide conjugates 2a and 38,
prepared from starting peptides 1a (H-UAF-OMe) and 24
(H-UHISKY-NH2), were explored over 16 hrs at varying pH
(2–9), elevated temperature, exposure to UV radiation, and in
Figure 6. Ligation-conjugation reactions; Additive-free ligation conditions: 5 mM wrt selenol monomer (2.5 mM wrt diselenide dimer), and Cys-
peptide, 1.05 equiv. selenoester; Conjugation protocol A; 2.5 mM peptide (wrt selenol monomer), 50 equiv. TCEP, 2 equiv. TEMPO trap, 4 equiv.
Mn(OAc)3, 50 8C, 1 hour; Protocol C; 2.5 mM peptide (wrt selenol monomer), 50 equiv. TCEP, 5 equiv. TEMPO trap, 37 8C, 4 hours; Protocol D;
2.5 mM peptide, 50 equiv. TCEP, 2 equiv. TEMPO trap, 10 equiv. Mn(OAc)3, 50 8C, 4 hours; [a] Overall yield over 2 steps.
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the presence of additives, including; VA-044 (a radical
initiator) and glutathione (see Tables S15 and S16 for details).
The conjugate was found to be remarkably stable under the
conditions explored. However, the aminooxy linker is labile
in the presence of a low oxidation state transition metal in
mildly acidic conditions. Introduction of 10 equiv. of Zn0 in
10% acetic acid resulted in quantitative and clean degrada-
tion of the linker to leave a Ser residue at the site of
conjugation. This protocol was applied to purified conjugate
28 with successful and exceptionally clean release of the
propargyl trap to afford 39 in high yield (92 %) (Figure S103).
To evaluate this method as a potential technique to achieve
peptide ligation at a Ser residue, we investigated a one-pot
DSL-TEMPO conjugation-reductive cleavage protocol (Fig-
ure 7). Selenoester model 23 and diselenide model 21 were
ligated via standard DSL conditions. Following hexane
extraction of the precipitated DPDS, conjugation protocol A
was carried out using TEMPO to afford conjugate 40. To
effect reductive cleavage of the aminooxy linkage of the
conjugate in the crude mixture at 1 mM wrt 40, 0.5 M Zn0 was
required in 10 vol.% AcOH. The cleavage was complete after
16 h and the desired peptide (41), bearing a Ser residue at the
ligation site, was isolated in good yield (74 %). This protocol is
thus comparable to the previously reported Oxone-TCEP
method for programmable ligation at Ser (Figure S111).[48–49]
Finally, we applied our conjugation reaction to two larger,
more complex polypeptide systems. To fully demonstrate the
scope of the one-pot ligation-conjugation protocol, the affi-
body, ZEGFR:1907 (a 58 mer peptide derived from immunoglo-
bin-binding protein A)[53] was synthesized as two fragments;
selenoester 42 (amino acids 1–28) and diselenide 43 (amino
acids 29–58). These two peptides were ligated under standard
DSL conditions and, following hexane extraction of the
precipitated DPDS, the propargyl-TEMPO trap 4 was con-
jugated using protocol A. The desired conjugate 44 was
isolated in a 42 % one-pot yield (Figure 8).
To demonstrate our conjugation method on a biologically
expressed protein sample, a K48C mutant of ubiquitin (45)
was prepared via recombinant expression in E. coli.[54] It was
observed that modification of Cys within a protein required
slightly higher equiv. than present in protocol D. Therefore, at
1 mM protein concentration, the propargyl-TEMPO trap 4
was conjugated using 100 mM TCEP, 5 mM 4, and 20 mM
Mn(OAc)3 at 50 8C for 2 hours (protocol E). The product was
purified by preparative HPLC and desired conjugate 46
isolated in 62% yield (Figure 9). Purified Ub conjugate 46
and the K48C mutant 45 were re-dissolved in ligation buffer
and folded via dialysis into 25 mM Na2HPO4, 100 mM NaCl,
pH 6.9. The samples were analysed via 1H NMR and assigned
by comparison to the published data.[55] Both conjugate 46
and K48C mutant 45 showed extended NH regions (6.5–
9.5 ppm) and upshifted methyl groups indicating formation of
the native tertiary structure (figs S121–S123). A comparison
of the chemical shift values of the NH signals for 45 and 46
shows very little deviation across the majority of the sequence
(Figure S120). As expected, those residues flanking modified
position 48 do experience minor perturbations in chemical
shift due to the installed moiety.
Figure 7. One-pot ligation at Ser; DSL of model fragments 23 and 21,
followed by conjugation of TEMPO and reductive cleavage, affords the
desired peptide bearing Ser at the ligation junction.
Figure 8. One-pot ligation-conjugation of ZEGFR:1907 affibody (native
sequence shown): DSL of fragments 42 and 43 followed by conjuga-
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Conclusion
In summary, we have developed a novel approach to site-
selective polypeptide modification via trapping of free-
radical-mediated dechalcogenation. The reaction is opera-
tionally very simple (carried out on the bench in an open
vessel, with no requirement to degas the solutions), and
tolerant to a diverse range of moieties appended to a persis-
tent radical trap. Crucially, we demonstrate that the stereo-
chemistry of the a-center of the modified Sec or Cys residue is
retained during conjugation. Reagent stoichiometry has been
optimized throughout (protocols A–E, see table S1) to
demonstrate rapid labelling within 30–60 minutes for Sec
residues and slightly longer for Cys (2–4 hrs). The reaction is
effective down to a concentration of 100 mM (over 16 hrs,
Figure 4A), and selective for Sec in the presence of Cys. The
aminooxy linker of the conjugate is stable under the
conditions explored and can be controllably degraded in mild
acid with the addition of Zn0 with exceptionally clean release.
The method affords good–excellent yields on simple model
systems and this efficiency translates well onto larger and
more complex peptides and proteins carrying a wealth of
chemical diversity. While conjugation to an internal Cys
residue within a recombinantly expressed protein (ubiquitin)
required a higher excess of the reagents relative to the peptide
models, this increase does not translate into a significant
quantity of material at the scale appropriate for protein
chemistry. In addition, the functionalised TEMPO-based
traps can be synthesised on the gram-scale in high yield,
and the TCEP and Mn(OAc)3 reagents are relatively
inexpensive. Beyond direct modification of polypeptides, we
have applied our approach to advance the toolkit of ligation
chemistry. We report a DSL-conjugation protocol that
enables the one-pot chemical synthesis and modification of
large peptides and small proteins. Furthermore, by exploiting
the lability of the aminooxy linker to low oxidation state
transition metals, we have developed a one-pot ligation-
conjugation-reductive cleavage technique that allows peptide
ligation at Ser residues.
The tolerance, selectivity, and operational simplicity of
this novel method, coupled with the versatility of the amino-
oxy linker, will enable researchers to employ the described
protocols to prepare polypeptide-small molecule conjugates
suitable for a diverse range of applications.
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Site-Selective Modification of Peptides
and Proteins via Interception of Free-
Radical-Mediated Dechalcogenation
Functionalization of peptides and pro-
teins through the trapping of peptide
radical species is described. This novel
and versatile strategy exploits the process
of desulfurization and deselenization of
cysteine and selenocystine residues to
enable the site-selective installation of
a broad range of groups appended to
a persistent radical trap.
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